Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (81-90 of 347) with videos related to

Pageof 35
Sort By:
Anticancer Research|December 12, 2003
Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysisKolja Freier, Franz X Bosch, Christa Flechtenmacher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
The Lancet. Oncology|May 4, 2012
Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological studyMatthias Kloor, Cathrin Huth, Anita Y Voigt, et al.
Cancer Research|July 19, 2005
Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancersMatthias Kloor, Christina Becker, Axel Benner, et al.
Plos One|March 20, 2012
Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastomaArne Christians, Christian Hartmann, Axel Benner, et al.
Leukemia Research|March 15, 2006
One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?Christina Schmitt, Alexander Grundt, Christian Buchholtz, et al.
Blood|October 24, 2002
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group UlmStefan Fröhling, Richard F Schlenk, Jochen Breitruck, et al.
Blood|May 31, 2002
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genesChristian Korz, Armin Pscherer, Axel Benner, et al.
European Journal of Haematology|March 24, 2009
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemiaChristian Geisler, Jesper Jurlander, Lars Bullinger, et al.
Nucleic Acids Research|March 9, 2007
Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastomaStefan Pfister, Christof Schlaeger, Frank Mendrzyk, et al.
Pageof 35

Showing results (81-90 of 347) with videos related to

Sort By:
Pageof 35
Anticancer Research|December 12, 2003
Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysisKolja Freier, Franz X Bosch, Christa Flechtenmacher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
The Lancet. Oncology|May 4, 2012
Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological studyMatthias Kloor, Cathrin Huth, Anita Y Voigt, et al.
Cancer Research|July 19, 2005
Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancersMatthias Kloor, Christina Becker, Axel Benner, et al.
Plos One|March 20, 2012
Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastomaArne Christians, Christian Hartmann, Axel Benner, et al.
Leukemia Research|March 15, 2006
One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?Christina Schmitt, Alexander Grundt, Christian Buchholtz, et al.
Blood|October 24, 2002
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group UlmStefan Fröhling, Richard F Schlenk, Jochen Breitruck, et al.
Blood|May 31, 2002
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genesChristian Korz, Armin Pscherer, Axel Benner, et al.
European Journal of Haematology|March 24, 2009
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemiaChristian Geisler, Jesper Jurlander, Lars Bullinger, et al.
Nucleic Acids Research|March 9, 2007
Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastomaStefan Pfister, Christof Schlaeger, Frank Mendrzyk, et al.
Pageof 35